Compare Minna Padi Investama Sekuritas Tbk. (PADI) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Minna Padi Investama Sekuritas Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Minna Padi Investama Sekuritas Tbk. trades at Rp80 (market cap 984.07B, 992.74M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,610 (market cap 11.64T, 278.4K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 11.8× Minna Padi Investama Sekuritas Tbk.'s market cap, and Minna Padi Investama Sekuritas Tbk. is more actively traded (992.74M versus 278.4K). Which is the better fit depends on your goals.
| PADI | TSPC | |
|---|---|---|
Market Cap | 984.07B | 11.64T |
Volume | 992.74M | 278.4K |
Lot | 9.93M | 2.78K |
Turnover | 78.44B | 723.93M |
Average Price | 79.02 | 2,600.31 |
Value | 78.44B | 723.93M |
Indicative Equilibrium Price | 80 | 2,610 |
Indicative Equilibrium Volume | 97.64K | 74 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Minna Padi Investama Sekuritas Tbk.
PT Minna Padi Investama Tbk (formerly PT Batavia Artatama Securindo) was established by No Deed. 79 dated May 28, 1998 of Notary Drs. Atrino Leswara, SH. This Deed has been approved by the Ministry of Justice of the Republic of Indonesia in his Decree No. C2-8234.HT 01.01.Th.98 dated July 3, 1998 and was published in the Official Gazette Republic of Indonesia No.. 86 dated October 27, 2006, Supplement. 11489.
Read more on PADI →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
